A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 75 GBX 3.45% Market Closed
Market Cap: 28.3m GBX
Have any thoughts about
Arecor Therapeutics PLC?
Write Note

Relative Value

The Relative Value of one AREC stock under the Base Case scenario is 19.88 GBX. Compared to the current market price of 75 GBX, Arecor Therapeutics PLC is Overvalued by 73%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AREC Relative Value
Base Case
19.88 GBX
Overvaluation 73%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
68
Median 3Y
9.2
Median 5Y
9.2
Industry
7.5
Forward
7.6
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.3
Industry
24.5
Forward
-958.1
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-7.1
Industry
20.2
vs History
vs Industry
Median 3Y
-5
Median 5Y
-6.6
Industry
23.4
vs History
3
vs Industry
26
Median 3Y
4.5
Median 5Y
4.8
Industry
3.1
vs History
61
vs Industry
60
Median 3Y
7.8
Median 5Y
7.8
Industry
8.2
Forward
7.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.7
vs History
vs Industry
1
Median 3Y
-4.9
Median 5Y
-5.7
Industry
6
Forward
-5.9
vs History
vs Industry
1
Median 3Y
-4.7
Median 5Y
-5.5
Industry
6.4
Forward
-5.3
vs History
vs Industry
1
Median 3Y
-4.7
Median 5Y
-6
Industry
7.1
vs History
vs Industry
2
Median 3Y
-4.6
Median 5Y
-5.8
Industry
5.7
vs History
36
vs Industry
40
Median 3Y
11.2
Median 5Y
11.6
Industry
5.3

Multiples Across Competitors

AREC Competitors Multiples
Arecor Therapeutics PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Arecor Therapeutics PLC
LSE:AREC
28.3m GBP 5.6 -3.5 -5.1 -4.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 293 983.5 -162 994.2 -197 927 -195 668.4
US
Abbvie Inc
NYSE:ABBV
387.1B USD 6.6 104 16.9 24.6
US
Amgen Inc
NASDAQ:AMGN
172.3B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
147.6B USD 5.1 18.2 12.2 12.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 054.3 -524.2 -570.8 -555.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104B USD 8.9 28.3 20.6 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.2B USD 4.9 15.1 14.2 16.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
58B USD 23.6 -181.7 -454 -311.6
AU
CSL Ltd
ASX:CSL
86.7B AUD 3.6 18.8 12.7 15.8
NL
argenx SE
XBRU:ARGX
44.7B EUR 14.3 33.7 58.1 59.7
P/E Multiple
Earnings Growth PEG
UK
A
Arecor Therapeutics PLC
LSE:AREC
Average P/E: 34.7
Negative Multiple: -3.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 994.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
104
89%
1.2
US
Amgen Inc
NASDAQ:AMGN
24.6
44%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.2
191%
0.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -524.2 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
8%
1.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -181.7 N/A N/A
AU
CSL Ltd
ASX:CSL
18.8
11%
1.7
NL
argenx SE
XBRU:ARGX
33.7
37%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
A
Arecor Therapeutics PLC
LSE:AREC
Average EV/EBITDA: 21.8
Negative Multiple: -5.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 927 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.9
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.8
10%
1.8
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
7%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -570.8 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.6
16%
1.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
9%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -454 N/A N/A
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
NL
argenx SE
XBRU:ARGX
58.1
769%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
A
Arecor Therapeutics PLC
LSE:AREC
Average EV/EBIT: 24
Negative Multiple: -4.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 668.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.6
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
19%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
13%
0.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -555.6 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.5
17%
1.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
12%
1.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -311.6 N/A N/A
AU
CSL Ltd
ASX:CSL
15.8
11%
1.4
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A